分子对接和动力学显示,CCNB2是HNSCC中的lncRNA ADAMTS9-AS1-002的功能标
Manish Kumar Mishra1, Sachin Gupta2, Pramod Kalsotra2
1Centre for Molecular Biology, Central University of Jammu, Jammu, J&K, India.
Biochemical and biophysical research communications
|December 3, 2025
概括
这项研究揭示了ADAMTS9-AS1-002和HPV阳性头癌中Cyclin B2之间的关键相互作用,影响细胞循环调节和瘤生长. 这一发现为癌症治疗提供了潜在的新目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 头部和部状细胞癌 (HNSCC) 经常与HPV感染有关,导致细胞循环失调和瘤进展.
- 长非编码RNAs (lncRNAs) 在癌症发展中起着至关重要的作用,但它们在HPV阳性HNSCC中的特定功能尚未完全理解.
研究的目的:
- 研究新型lncRNA ADAMTS9-AS1-002与HPV阳性HNSCC中的细胞循环调节剂Cyclin B2 (CCNB2) 之间的相互作用.
- 探索这种相互作用对瘤病理学的功能影响,并确定潜在的治疗点.
主要方法:
- 基因表达数据的综合生物信息学分析 (GEO数据集 GSE250305).
- 基因本体学 (GO) 和KEGG通路丰富分析.
- 在蛋白-RNA对接 (HDOCK,HADDOCK) 和分子动力学模拟.
- 识别相互作用区域和关键残留物.
主要成果:
- 鉴定了420个与ADAMTS9-AS1-002标相关的差异表达基因 (DEGs),在RNA处理和细胞周期调节方面得到丰富.
- 在HPV阳性HNSCC中,CCNB2显著上调,并与ADAMTS9-AS1-002.2显示出稳定的相互作用.
- 相互作用涉及CCNB2的氨酸丰富区域,表明与细胞增殖的功能联系.
结论:
- lncRNA ADAMTS9-AS1-002与CCNB2相互作用,导致HPV阳性HNSCC中不受控制的细胞增殖.
- CCNB2 作为 ADAMTS9-AS1-002.2. 的下游效应器.
- 这种相互作用为HPV阳性头癌的治疗策略提供了有希望的分子特征.
相关概念视频
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


